GBP0.07
2.14% today
London, Jul 03, 09:50 am CET
ISIN
GB00BYWL4Y04
Symbol
RENX

Renalytix AI plc Stock price

GBP0.07
-0.00 3.45% 1M
-0.05 39.13% 6M
-0.04 34.88% YTD
-0.04 36.36% 1Y
-1.11 94.04% 3Y
-5.58 98.76% 5Y
-1.13 94.17% 10Y
-1.13 94.17% 20Y
London, Closing price Wed, Jul 02 2025
+0.00 0.00%
ISIN
GB00BYWL4Y04
Symbol
RENX

Key metrics

Basic
Market capitalization
GBP23.2m
Enterprise Value
-
Net debt
-
Cash
-
Shares outstanding
Valuation (TTM | estimate)
P/E
negative | negative
P/S
13.32 | 3.07
EV/Sales
- | -
EV/FCF
-
P/B
-
Financial Health
Equity Ratio
-126.61%
Return on Equity
506.12%
ROCE
-
ROIC
-
Debt/Equity
-
Financials (TTM | estimate)
Revenue
GBP1.7m | GBP7.5m
EBITDA
GBP-21.3m | GBP-12.1m
EBIT
GBP-22.2m
Net Income
GBP-25.5m | -
Free Cash Flow
GBP-16.7m
Growth (TTM | estimate)
Revenue
-1.69% | 349.27%
EBITDA
19.96% | 42.21%
EBIT
22.06%
Net Income
18.82% | -
Free Cash Flow
35.39%
Margin (TTM | estimate)
Gross
20.95%
EBITDA
-1,227.99% | -159.80%
EBIT
-1,279.05%
Net
-1,466.86% | -
Free Cash Flow
-961.89%
More
EPS
GBP-0.15
FCF per Share
Short interest
58.00%
Employees
102.00
Rev per Employee
GBP20.00k
Show more

Is Renalytix AI plc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,965 stocks worldwide.

Renalytix AI plc Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Renalytix AI plc forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a Renalytix AI plc forecast:

Buy
80%
Hold
20%

Financial data from Renalytix AI plc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1.74 1.74
2% 2%
100%
- Direct Costs 1.37 1.37
17% 17%
79%
0.36 0.36
200% 200%
21%
- Selling and Administrative Expenses 15 15
48% 48%
857%
- Research and Development Expense - -
-
-
-21 -21
20% 20%
-1,226%
- Depreciation and Amortization 0.89 0.89
52% 52%
51%
EBIT (Operating Income) EBIT -22 -22
22% 22%
-1,277%
Net Profit -25 -25
19% 19%
-1,465%

In millions GBP.

Don't miss a Thing! We will send you all news about Renalytix AI plc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Renalytix AI Plc manufactures medical devices and equipment. It offers artificial intelligence for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in Penarth, the United Kingdom.

Head office United Kingdom
CEO James McCullough
Employees 102
Founded 2018
Website renalytix.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today